Opening Remarks

Tom Maniatis, PhD

Evnin Family Scientific Director and CEO, New York Genome Center

Professor, Zuckerman Institute, Columbia University

2:00 pm - 2:30 pm

Anne-Catrin Uhlemann, MD, PhD

Associate Professor of Medicine, Division of Infectious Diseases, College of Physicians and Surgeons, Columbia University

“Emergence of B.1.526 in New York”

2:30 pm - 3:00 pm

Emma Winkler

MD/PhD program in Immunology, Washington University in St Louis School of Medicine

“Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection”

3:00 pm - 3:30 pm

Lawrence S. Shapiro, PhD

Professor, Biochemistry and Molecular Biophysics and Ophthalmic Science; Principal Investigator, Zuckerman Institute, Columbia University 

“Neutralization of SARS-CoV-2 by Antibody”

3:30 pm - 4:00 pm

Emilia Mia Sordillo, MD, PhD, FACP, FIDSA

Associate Professor, Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai; System Director, Microbiology, MSHS; Medical Director, Mount Sinai Morningside Laboratory; Assistant Medical Director, Mount Sinai Beth Israel Laboratory

“SARS-CV-2 in New York City: Before the Surge”